<DOC>
	<DOCNO>NCT01022983</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy Levosimendan give preoperative patient heart failure undergo noncardiac surgery .</brief_summary>
	<brief_title>Preoperative Levosimendan Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Acute surgery . Hip Fracture Patient cardiac failure ( EF &lt; 35 % ) know coronary disease At least 2 11 comorbidities Patient use least one heart failure medication Symptoms heart failure NTproBNP &gt; 2000pg/ml &lt; 18 year old Participants pharmacological study Abuse medicament alcohol Pregnant breastfeeding woman AMI admission HOCM Serious aortic stenosis ( &lt; 1 cm2 ) Sustained ventricular tachycardia Earlier episodes `` torsades de pointes '' Sustained heartbeat &gt; 120/minute Systolic BP &lt; 90 mmHg Surgery plan 2 hour study medication infuse preoperative Cardiac surgery Dementia SK &lt; 3 mmol/l Allergy levosimendan Serious liver failure ( Known Class C ChildPugh score ) Serious kidney failure ( GFR &lt; 30 ml/min . ) Prolonged QTcinterval ( male QTc &gt; 0,43 , female QTc &gt; 0,45 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>